Home

Biorecognition

Main content

Protein ribbon model

We are interested in the molecular mechanisms behind biomolecular recognition and functional response.
 

The Biorecognition Group studies the relationship between molecular structure and function to understand human health and disease. We use a combination of computational and experimental techniques, within the fields of biophysics, biochemistry and cellular biology. We aim to develop new therapeutic options for inborn errors of metabolism, in particular Phenylketonuria and neurotransmitter disorders (e.g. tyrosine hydroxylase deficiency).

Permanent staff:

Professor Aurora Martinez

Ming Ying, chief engineer
 

The Biorecognition Group constitutes one of four groups/labs in the Structural biology and drug discovery research unit.

News | Research
Bilde av to mus i musemodellen holdt av to personer med blå hansker

A new mouse model gave surprising findings about Folling Disease

A new study from the University in Bergen may shed light on the comorbidities found in adults suffering from this rare disease.

Research project
PRIME logo

New mental health project aims to uncover insulin-related mechanisms linking disorders of body and brain.

An important European-funded initiative has been launched to explore how common molecular mechanisms may link metabolic disorders, especially type 2 diabetes and obesity, with brain disorders such as Alzheimer's disease, obsessive-compulsive disorder, and autism spectrum disorders. Jan Haavik and...

News
graphical abstract mol therapy

From molecule to medicine

Martinez and collaborators are developing a pharmacological chaperone therapy for acute intermittent porphyria